• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24894 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     Quality Improvement Scotland (NHS QIS ) Varenicline for smoking cessation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Varenicline for smoking cessation in patients with psychiatric illness: a review of the risks
2007     National Institute for Health and Care Excellence (NICE) Varenicline for smoking cessation. NICE technology appraisal guidance 123
2009     NIHR Health Technology Assessment programme Varenicline in the management of smoking cessation: a single technology appraisal
2001     Health Council of the Netherlands Gezondheidsraad (GR) Variant Creutzfeldt-Jakob disease and blood transfusion - review, expert panel
2014     NIHR Health Services and Delivery Research programme Variation in compulsory psychiatric inpatient admission in England: a cross-sectional, multilevel analysis
2025     NIHR Health Technology Assessment programme Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study
2017     NIHR Health Services and Delivery Research programme Variations in mortality across the week following emergency admission to hospital: linked retrospective observational analyses of hospital episode data in England, 2004/5 to 2013/14
2014     NIHR Health Services and Delivery Research programme Variations in outcome and costs among NHS providers for common surgical procedures: econometric analyses of routinely collected data
1996     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Variations in rates of tonsillectomy, adenoidectomy and myringotomy in Quebec - nonsystematic review
1993     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Variations in the frequency of surgical procedures by region in the province of Quebec - nonsystematic review
2020     NIHR Health Services and Delivery Research programme Variations in the organisation of Early Pregnancy Assessment Units (EPAUs) in the UK and their effects on clinical, service and patient-centred outcomes (VESPA)
2014     New Zealand National Health Committee (NHC) Varicella and rotovirus vaccination in New Zealand - assessment reports
2000     University HealthSystem Consortium (UHC) Varicella-zoster
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Vascular bipolar electrocoagulation (LigaSure (TM)) and Tissular electrocoagulation and section (TissueLink (TM)) - preliminary report
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment
1989     The Swedish Council on Health Technology Assessment (SBU) Vascular surgery for arteriosclerosis in the legs
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2013     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2015     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review (update)
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vasoprotectives: efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids
2003     Centre for Clinical Effectiveness (CCE) Vasospasm following subarachnoid haemorrhage: papaverine infusion, nimodipine infusion or balloon angioplasty?
2005     Adelaide Health Technology Assessment (AHTA) Vasotrac (R) continuous blood pressure monitoring
2009     HAYES, Inc. VasoView HemoPro endoscopic vein harvesting system (Maquet Cardiovascular LLC) for coronary artery bypass graft (CABG)
2012     NIHR Horizon Scanning Centre (NIHR HSC) VBLOC® vagal blocking therapy for obesity
2022     Scottish Health Technologies Group (SHTG) vCreate Neuro for the diagnosis and treatment of adults and children with epilepsy and other neurological disorders
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for Crohn's disease – second or subsequent line
2022     National Institute for Health and Care Excellence (NICE) Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal). NICE technology appraisal guidance 826
2014     NIHR Health Technology Assessment programme Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]
2015     National Institute for Health and Care Excellence (NICE) Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy. NICE technology appraisal guidance 352
2015     National Institute for Health and Care Excellence (NICE) Vedolizumab for treating moderately to severely active ulcerative colitis. NICE technology appraisal guidance 342
2019     Agency for Care Effectiveness (ACE) Vedolizumab for treating ulcerative colitis and Crohn's disease
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for ulcerative colitis – second or subsequent line
2011     NIHR Horizon Scanning Centre (NIHR HSC) VEGF trap-eye (Eylea) for macular oedema secondary to central retinal vein occlusion - first line
2024     NIHR Health Technology Assessment programme Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT
1998     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Vein-graft surveillance - primary research
2012     HAYES, Inc. VeinViewer (Christie Digital Systems USA Inc.) for guiding venous access procedures in children
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Velaglucerase alfa
2009     NIHR Horizon Scanning Centre (NIHR HSC) Velaglucerase alfa for type 1 Gaucher's disease
2010     HAYES, Inc. Velcade (Bortezomib) (Millennium: The Takeda Oncology Company) for mantle cell lymphoma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Velcalcetide for secondary hyperparathyroidism – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Velimogene aliplasmid (Allovectin) for advanced or metastatic malignant melanoma
2016     NIHR Horizon Scanning Centre (NIHR HSC) Veliparib with carboplatin and paclitaxel for early-stage triple negative breast cancer ─ neoadjuvant therapy
2023     National Institute for Health and Care Excellence (NICE) Velmanase alfa for treating alpha-mannosidosis. NICE highly specialised technologies guidance 29
2010     Adelaide Health Technology Assessment (AHTA) Velscope for oral cancer screening
2008     Adelaide Health Technology Assessment (AHTA) Velscope(R) for oral cancer screening
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2014     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib and cobimetinib for previously untreated BRAFV600-mutation positive, unresectable, locally advanced or metastatic melanoma – first line
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vemurafenib for the 1st –line unresectable stage IIIC or IV melanoma
2012     NIHR Health Technology Assessment programme Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma
2012     National Institute for Health and Care Excellence (NICE) Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. NICE technology appraisal guidance 269
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Venetoclax (Venclexta™) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) with chromosome 17p deletion
2015     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2022     National Institute for Health and Care Excellence (NICE) Venetoclax for treating chronic lymphocytic leukaemia. NICE technology appraisal guidance 796
2022     National Institute for Health and Care Excellence (NICE) Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable. NICE technology appraisal guidance 765
2022     National Institute for Health and Care Excellence (NICE) Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable. NICE technology appraisal guidance 787
2026     National Institute for Health and Care Excellence (NICE) Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia. NICE technology appraisal guidance 1119
2020     National Institute for Health and Care Excellence (NICE) Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia. NICE technology appraisal guidance 663
2019     National Institute for Health and Care Excellence (NICE) Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia. NICE technology appraisal guidance 561
2016     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax with rituximab for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line
2021     NIHR Health Technology Assessment programme Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT
2021     Penn Medicine Center for Evidence-based Practice (CEP) Venous irritation resulting from IV fosaprepitant
2018     Penn Medicine Center for Evidence-based Practice (CEP) Venous Thromboembolism Prevention for Obese Patients
2009     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for bariatric surgery
2007     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for hip fracture patients
2007     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for ischemic stroke
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines
2007     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for medical inpatients
2012     Agency for Healthcare Research and Quality (AHRQ) Venous thromboembolism prophylaxis in orthopedic surgery
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Ventilation in operating theatres
2013     New Zealand National Health Committee (NHC) Ventilation tubes: an opportunity for better targeting - technology note
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ventral rectopexy for the treatment of rectal prolapse and intussusception
2005     HAYES, Inc. Ventricular assist devices
2003     HAYES, Inc. Ventricular assist devices
2010     HAYES, Inc. Ventricular Assist Devices (VADs) in children and adolescents with chronic, end-stage heart failure
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ventricular assistance devices as mechanical bridge to cardiac transplantation (internal report) IPE-97/f
2003     HAYES, Inc. Ventricular reduction surgery
2004     NIHR Health Technology Assessment programme VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers
2009     NIHR Health Technology Assessment programme VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers
2011     NIHR Health Technology Assessment programme VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2014     NIHR Health Technology Assessment programme VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vepoloxamer for vaso-occlusive crises in sickle cell disease – first line
2016     HAYES, Inc. Verasense (OrthoSensor Inc.) for use during total knee arthroplasty
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Veress needle laparoscopic entry technique
2021     National Institute for Health and Care Excellence (NICE) Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal). NICE technology appraisal guidance 731
2016     HAYES, Inc. VeriStrat
2014     HAYES, Inc. VeriStrat test to predict response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC)
2012     HAYES, Inc. VeriStrat® Test to predict response to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC)
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vernakalant (IV) (Brinavess) for the treatment of recent onset atrial fibrillation
2021     National Institute for Health and Care Excellence (NICE) Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal). NICE technology appraisal guidance 675
2011     HAYES, Inc. VersaJet hydrosurgery system (Smith&Nephew Inc.) for treatment of burns
2021     Malaysian Health Technology Assessment (MaHTAS) Versajet hydrosurgery system for wound debridement: an update
2013     HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012     HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2019     NIHR Health Technology Assessment programme Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT
2004     Blue Cross Blue Shield Association (BCBS) Vertebral assessment using dual-energy x-ray absorptiometry for osteoporotic fracture risk assessment
2007     Adelaide Health Technology Assessment (AHTA) Vertebral assessment with DEXA